Charles Schwab Investment Management Inc Collegium Pharmaceutical, Inc Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 364,839 shares of COLL stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
364,839
Previous 340,433
7.17%
Holding current value
$14 Million
Previous $13.2 Million
11.11%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding COLL
# of Institutions
236Shares Held
39.4MCall Options Held
84.2KPut Options Held
18.6K-
Black Rock Inc. New York, NY5.79MShares$222 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$130 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$101 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$90.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$89.3 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.31B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...